ArticleBMJ open2025

Clinical utility and cost-effectiveness of BeginNGS newborn screening by genome sequencing and standard newborn screening for severe childhood genetic diseases: an adaptive, international and comparative clinical trial.

Rebecca Reimers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.